• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Gevo, Inc. (GEVO)

    0.41 Down 0.01(3.48%) Feb 5, 3:59PM EST
    |After Hours : 0.46 Up 0.04 (10.92%) Feb 5, 5:26PM EST
    ProfileGet Profile for:
    Gevo, Inc.
    345 Inverness Drive South
    Building C
    Englewood, CO 80112
    United States - Map
    Phone: 303-858-8358
    Website: http://www.gevo.com

    Index Membership:N/A
    Sector:Basic Materials
    Industry:Chemicals - Major Diversified
    Full Time Employees:97

    Business Summary 

    Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The company operates in two segments, Gevo, Inc.; and Gevo Development/Agri-Energy. The company engages in the research and development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of biojet fuel; and retrofit process of chemicals and biofuels. It is also involved in the production of ethanol, isobutanol, and related products. Gevo, Inc. produces and separates its renewable isobutanol through the Gevo Integrated Fermentation Technology platform. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Gevo, Inc.

    Corporate Governance 
    Gevo, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 10. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 7; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Patrick R. Gruber Ph.D., MBA, 55
    Chief Exec. Officer and Director
    Dr. Christopher Ryan Ph.D., 55
    Pres, Chief Operating Officer and Chief Technology Officer
    Mr. Mike Willis , 46
    Chief Financial Officer, Principal Accounting Officer and Exec. VP of Corp. Devel. & Strategy
    Mr. Greg Roda , 56
    Chief Commercial Officer
    Dr. Frances Hamilton Arnold Ph.D.,
    Co-Founder, Consultant and Member of Scientific Advisory Board
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders